Xenetic Biosciences is trading at $3.58, down -6.04%, amid possible profit-taking after consecutive advances. - No newly identified company-specific announcement was reported on August 25, 2026; the latest update was the August 7 second-quarter report. - Shares gained 6.13% on August 24 and 5.90% on August 21. - The broader biotech sector is higher, so sector weakness does not explain the decline.